Factors moving the U.S. stock market including oil prices Treasury yields technology stocks and geopolitical risks
U.S. stock futures traded near the flatline Wednesday as higher oil prices, elevated Treasury yields, and weakness in technology stocks weighed on investor sentiment.
Dow Jones Industrial Average futures and S&P 500 futures edged slightly higher, while Nasdaq-100 futures fell 0.2%, reflecting continued pressure on major technology and semiconductor stocks.
Investors were also monitoring rising crude oil prices, inflation concerns, movements in Treasury yields, and several major premarket stock movers, including Oracle, Alphabet, Moderna, and Merck.
U.S. Stock Futures Mixed as Nasdaq-100 Declines
U.S. equity futures showed limited movement ahead of the market open.
Dow Jones Industrial Average futures and S&P 500 futures traded slightly above the flatline.
Meanwhile, Nasdaq-100 futures declined 0.2%, as weakness in technology stocks continued to pressure the tech-heavy index.
The mixed performance came as investors assessed higher energy prices, movements in global bond markets, inflation risks, and company-specific developments.
Oil Prices Rise Nearly 1% Amid Iran Concerns
Oil prices climbed nearly 1% Wednesday, adding another source of uncertainty for financial markets.
Crude prices moved higher following reports that Iran was considering an attack on a U.S. target in Europe.
Persistently elevated oil prices have increased concerns about renewed inflationary pressure. Higher energy costs can raise transportation and production expenses across the economy, potentially complicating the outlook for interest rates.
Rising crude prices have also contributed to higher bond yields globally, creating additional pressure on equity valuations.
Treasury Yields Ease After Recent Surge
Treasury yields eased slightly Wednesday following their latest advance.
The previous rise in bond yields had weighed on major U.S. stock indexes as investors reassessed the impact of higher borrowing costs and persistent inflation concerns.
Treasury yields remain an important factor for stock-market sentiment because higher yields can make bonds more attractive relative to equities while increasing financing costs for businesses.
Technology and other growth-oriented stocks can be particularly sensitive to changes in interest rates and bond yields.
Oracle Stock Falls Following Report on OpenAI Results
Oracle shares fell about 2% in premarket trading after The Wall Street Journal reported that OpenAI disclosed second-quarter financial results that disappointed investors.
According to the report, OpenAI revenue increased 18% between the first and second quarters, but the company’s losses also grew.
The development weighed on sentiment toward several technology companies.
Alphabet, Marvell and Intel Shares Move Lower
Alphabet shares were lower in early trading alongside semiconductor companies Marvell Technology and Intel.
The declines contributed to weakness in Nasdaq-100 futures and reinforced broader concerns surrounding technology stocks.
Technology companies are also facing pressure from elevated bond yields, which can reduce the present value investors assign to companies whose expected earnings are weighted toward future growth.
Moderna Stock Surges More Than 60% on Cancer Vaccine Results
While several technology stocks declined, Moderna emerged as one of the strongest premarket stock movers.
Moderna shares jumped more than 60% after an experimental cancer vaccine developed with Merck showed positive results in a late-stage trial.
The sharp move made Moderna one of the biggest premarket gainers of the session.
Merck shares also rose more than 6%, providing support to Dow futures.
What Is Moving the U.S. Stock Market Today?
Several major factors are influencing U.S. stock futures:
- Higher oil prices: Rising crude prices are increasing concerns about inflation.
- Treasury yields: Elevated bond yields continue to affect equity valuations and investor risk appetite.
- Technology stock weakness: Oracle, Alphabet, Marvell and Intel traded lower.
- Geopolitical risks: Developments involving Iran are adding uncertainty to oil and financial markets.
- Biotechnology gains: Moderna and Merck rallied following positive cancer vaccine trial results.
Market Outlook
U.S. stock futures remain under pressure from a combination of higher oil prices, elevated Treasury yields, geopolitical uncertainty and weakness in technology stocks.
Although Dow and S&P 500 futures remained close to unchanged, the decline in Nasdaq-100 futures indicated continued caution toward technology shares.
At the individual-stock level, Oracle and several major technology companies moved lower, while Moderna and Merck recorded significant gains following encouraging clinical trial results.
Investors will continue watching developments in oil markets, Treasury yields, technology shares and geopolitical tensions for further direction in U.S. equities.
FAQs
1. Why were U.S. stock futures trading near the flatline?
U.S. stock futures were little changed as investors weighed higher oil prices, elevated Treasury yields, geopolitical concerns involving Iran, and weakness in major technology stocks.
2. Why did Nasdaq-100 futures fall?
Nasdaq-100 futures declined as several technology and semiconductor stocks, including Oracle, Alphabet, Marvell Technology, and Intel, traded lower in early trading.
3. Why are higher oil prices affecting the stock market?
Higher oil prices can increase inflation concerns and raise costs for businesses and consumers. Persistent inflation can also influence interest-rate expectations and Treasury yields, which may pressure stock valuations.
4. Why did Moderna stock surge more than 60%?
Moderna shares jumped after an experimental cancer vaccine developed with Merck showed positive results in a late-stage trial. Merck shares also rose sharply following the news.
5. What should investors watch in the U.S. stock market today?
Key factors include movements in oil prices, Treasury yields, geopolitical developments, technology-stock performance, and major premarket movers such as Moderna, Merck, Oracle, and Alphabet.
